Search research articles
Contact Us
Filters
Showing results (11-20 of 237) with videos related to
Page
of 24
Sort By:
Kidney International Reports
|
June 14, 2019
Estimating GFR in the Elderly-New Approaches to an Old Problem
Meda E Pavkov, Robert G Nelson
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 8, 2014
Improved early risk stratification with cystatin C-based estimated GFR
Meda E Pavkov, Robert G Nelson
Kidney International
|
June 26, 2017
Reading the tree leaves-how to enrich clinical trials of diabetic kidney disease
Helen C Looker, Robert G Nelson
Advances in Chronic Kidney Disease
|
March 28, 2018
Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease
Helen C Looker, Michael Mauer, Robert G Nelson
Kidney International
|
January 6, 2020
Do sodium-glucose cotransporter-2 inhibitors affect renal hemodynamics by different mechanisms in type 1 and type 2 diabetes?
Petter Bjornstad, Robert G Nelson, Meda E Pavkov
The Lancet. Diabetes & Endocrinology
|
April 4, 2022
Dapagliflozin in young people with type 2 diabetes
Kalie L Tommerdahl, Robert G Nelson, Petter Bjornstad
The New England Journal of Medicine
|
November 17, 2021
Long-Term Complications in Youth-Onset Type 2 Diabetes
Robert G Nelson, Robert L Hanson, William C Knowler
The New England Journal of Medicine
|
August 30, 2005
Cystatin C and the risk of death
Bruce A Perkins, Robert G Nelson, Andrzej S Krolewski
Clinical Science (London, England : 1979)
|
November 3, 2022
Youth versus adult-onset type 2 diabetic kidney disease: Insights into currently known structural differences and the potential underlying mechanisms
Kalie L Tommerdahl, Jessica Kendrick, Robert G Nelson, et al.
Kidney International
|
June 4, 2013
The authors reply
E Jennifer Weil, Kevin V Lemley, Bryan D Myers, et al.
Page
of 24
Search research articles
Search
Showing results (11-20 of 237) with videos related to
Sort By:
Page
of 24
Kidney International Reports
|
June 14, 2019
Estimating GFR in the Elderly-New Approaches to an Old Problem
Meda E Pavkov, Robert G Nelson
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 8, 2014
Improved early risk stratification with cystatin C-based estimated GFR
Meda E Pavkov, Robert G Nelson
Kidney International
|
June 26, 2017
Reading the tree leaves-how to enrich clinical trials of diabetic kidney disease
Helen C Looker, Robert G Nelson
Advances in Chronic Kidney Disease
|
March 28, 2018
Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease
Helen C Looker, Michael Mauer, Robert G Nelson
Kidney International
|
January 6, 2020
Do sodium-glucose cotransporter-2 inhibitors affect renal hemodynamics by different mechanisms in type 1 and type 2 diabetes?
Petter Bjornstad, Robert G Nelson, Meda E Pavkov
The Lancet. Diabetes & Endocrinology
|
April 4, 2022
Dapagliflozin in young people with type 2 diabetes
Kalie L Tommerdahl, Robert G Nelson, Petter Bjornstad
The New England Journal of Medicine
|
November 17, 2021
Long-Term Complications in Youth-Onset Type 2 Diabetes
Robert G Nelson, Robert L Hanson, William C Knowler
The New England Journal of Medicine
|
August 30, 2005
Cystatin C and the risk of death
Bruce A Perkins, Robert G Nelson, Andrzej S Krolewski
Clinical Science (London, England : 1979)
|
November 3, 2022
Youth versus adult-onset type 2 diabetic kidney disease: Insights into currently known structural differences and the potential underlying mechanisms
Kalie L Tommerdahl, Jessica Kendrick, Robert G Nelson, et al.
Kidney International
|
June 4, 2013
The authors reply
E Jennifer Weil, Kevin V Lemley, Bryan D Myers, et al.
Page
of 24